These gene mutations—including APP, PS1, and PS2—belong to the familial form of AD and have been shown to increase the development of amyloid-β (Aβ) leading to an increase in the Aβ1–42/Aβ1–40 ratio, hence favoring the formation of senile plaques [1]. Here, PSEN1 is linked to Alzheimer disease.